Strategies to overcome the limitations of AIEgens in biomedical applications
Motivated by the demand for high‐performance tools for biomedical applications, numerous new luminescent nanomaterials with advanced functionalities are synthesized in recent years. Conventional fluorophores generally suffer from the notorious aggregation‐caused quenching effect that deteriorates th...
Saved in:
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/138472 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-138472 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1384722020-05-06T08:48:21Z Strategies to overcome the limitations of AIEgens in biomedical applications Gu, Bobo Yong, Ken-Tye Liu, Bin School of Electrical and Electronic Engineering Engineering::Electrical and electronic engineering Aggregation-Induced Emission Nanocrystallization Motivated by the demand for high‐performance tools for biomedical applications, numerous new luminescent nanomaterials with advanced functionalities are synthesized in recent years. Conventional fluorophores generally suffer from the notorious aggregation‐caused quenching effect that deteriorates their practical performance. The recently emerged fluorogens with aggregation‐induced emission (AIE) characteristics (AIEgen) have generated a new avenue for biomedical applications due to their unique optical properties, flexible designability, and multifunctional potential. However, the inherent characteristics of AIEgens, including short wavelength absorption, broad emission, and aggregation‐dependent brightness indirectly limit their practical performance in the biomedical field. Here, the recent development of AIEgens for biomedical applications is summarized and novel strategies to overcome their limitations are proposed. Furthermore, the strategies and guidelines for the rational design of AIEgens, preparation of water‐dispersible AIE nanoparticles, and selection of the excitation/emission methods, which enable AIEgens to be useful in a broader range of biomedical applications, are discussed. NRF (Natl Research Foundation, S’pore) ASTAR (Agency for Sci., Tech. and Research, S’pore) 2020-05-06T08:48:21Z 2020-05-06T08:48:21Z 2018 Journal Article Gu, B., Yong, K.-T., & Liu, B. (2018). Strategies to overcome the limitations of AIEgens in biomedical applications. Small Methods, 2(9), 1700392-. doi:10.1002/smtd.201700392 2366-9608 https://hdl.handle.net/10356/138472 10.1002/smtd.201700392 9 2 en Small Methods © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. All rights reserved. |
institution |
Nanyang Technological University |
building |
NTU Library |
country |
Singapore |
collection |
DR-NTU |
language |
English |
topic |
Engineering::Electrical and electronic engineering Aggregation-Induced Emission Nanocrystallization |
spellingShingle |
Engineering::Electrical and electronic engineering Aggregation-Induced Emission Nanocrystallization Gu, Bobo Yong, Ken-Tye Liu, Bin Strategies to overcome the limitations of AIEgens in biomedical applications |
description |
Motivated by the demand for high‐performance tools for biomedical applications, numerous new luminescent nanomaterials with advanced functionalities are synthesized in recent years. Conventional fluorophores generally suffer from the notorious aggregation‐caused quenching effect that deteriorates their practical performance. The recently emerged fluorogens with aggregation‐induced emission (AIE) characteristics (AIEgen) have generated a new avenue for biomedical applications due to their unique optical properties, flexible designability, and multifunctional potential. However, the inherent characteristics of AIEgens, including short wavelength absorption, broad emission, and aggregation‐dependent brightness indirectly limit their practical performance in the biomedical field. Here, the recent development of AIEgens for biomedical applications is summarized and novel strategies to overcome their limitations are proposed. Furthermore, the strategies and guidelines for the rational design of AIEgens, preparation of water‐dispersible AIE nanoparticles, and selection of the excitation/emission methods, which enable AIEgens to be useful in a broader range of biomedical applications, are discussed. |
author2 |
School of Electrical and Electronic Engineering |
author_facet |
School of Electrical and Electronic Engineering Gu, Bobo Yong, Ken-Tye Liu, Bin |
format |
Article |
author |
Gu, Bobo Yong, Ken-Tye Liu, Bin |
author_sort |
Gu, Bobo |
title |
Strategies to overcome the limitations of AIEgens in biomedical applications |
title_short |
Strategies to overcome the limitations of AIEgens in biomedical applications |
title_full |
Strategies to overcome the limitations of AIEgens in biomedical applications |
title_fullStr |
Strategies to overcome the limitations of AIEgens in biomedical applications |
title_full_unstemmed |
Strategies to overcome the limitations of AIEgens in biomedical applications |
title_sort |
strategies to overcome the limitations of aiegens in biomedical applications |
publishDate |
2020 |
url |
https://hdl.handle.net/10356/138472 |
_version_ |
1681057048812322816 |